article thumbnail

Antibody Drug Conjugates: windows of opportunity

Drug Target Review

Antibody drug conjugated with cytotoxic payload. antibody linked to a biologically active cytotoxic (anticancer) payload or drug 3d rendering. With the ultimate long-term goal of optimum dosing being determined before Phase 3 registration trials and before a drug is marketed. Cancer Cell [Internet].

article thumbnail

Women in STEM with Dr Petra Dieterich

Drug Target Review

About the author Dr Petra Dieterich, Senior Vice President at Abzena Petra has 30 years experience of in drug development in the pharmaceutical industry with a focus on supporting CMC activities. She has held leadership positions in Project Management, Technical Operations, and Business Development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlocking the potential of antibody drug conjugates

Drug Target Review

Jamie Rich, PhD is Senior Director of Technology, ADC Therapeutic Development at Zymeworks Inc. He has more than 17 years of experience in ADC and protein chemistry research and drug development. Dr Rich received a PhD in organic chemistry from the University of Alberta.

Drugs 69
article thumbnail

MicroED: From Powder to Structure in a Half-Hour

NIH Director's Blog: Drug Development

Now comes word of another absolutely incredible use of cryo-EM: determining with great ease and exquisite precision the structure of the smaller organic chemical compounds, or “small molecules,” that play such key roles in biological exploration and drug development.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

After graduating, Miles went on to work as a scientist on AstraZeneca’s Research and Development graduate programme, working on projects in biocatalysis, computational organic chemistry and machine learning for drug discovery.

article thumbnail

Empowering women in STEM: Navigating CMC regulatory affairs

Drug Target Review

After earning my undergraduate degree from Connecticut College, followed by a PhD in organic chemistry from the University of Michigan, I landed a position as a researcher at a large biopharmaceutical company. The future of CMC lies in embracing more agile, science-driven approaches to drug development and manufacturing.

Science 52